These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 8409400)
1. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400 [TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein. Leeuwenberg JF; Dentener MA; Buurman WA J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. Amura CR; Kamei T; Ito N; Soares MJ; Morrison DC J Immunol; 1998 Sep; 161(5):2552-60. PubMed ID: 9725255 [TBL] [Abstract][Full Text] [Related]
4. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. Schumann RR; Lamping N; Hoess A J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis. Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806 [TBL] [Abstract][Full Text] [Related]
6. Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages. Amura CR; Chen LC; Hirohashi N; Lei MG; Morrison DC J Immunol; 1997 Nov; 159(10):5079-83. PubMed ID: 9366436 [TBL] [Abstract][Full Text] [Related]
7. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370 [TBL] [Abstract][Full Text] [Related]
8. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030 [TBL] [Abstract][Full Text] [Related]
9. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein. Bülow E; Gullberg U; Olsson I J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106 [TBL] [Abstract][Full Text] [Related]
10. The BPI/LBP family of proteins: a structural analysis of conserved regions. Beamer LJ; Carroll SF; Eisenberg D Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897 [TBL] [Abstract][Full Text] [Related]
11. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Hubacek JA; Büchler C; Aslanidis C; Schmitz G Biochem Biophys Res Commun; 1997 Jul; 236(2):427-30. PubMed ID: 9240454 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI). Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348 [TBL] [Abstract][Full Text] [Related]
13. Interaction between CD14 lipopolysaccharide binding protein and bactericidal/permeability-increasing protein during lipopolysaccharide-induced cell activation. Dentener MA; Von Asmuth EJ; Francot GJ; Buurman WA Prog Clin Biol Res; 1994; 388():59-70. PubMed ID: 7530372 [No Abstract] [Full Text] [Related]
15. Protein fusions of BPI with CETP retain functions inherent to each. Lloyd DB; Bonnette P; Thompson JF Biochemistry; 2006 Oct; 45(43):12954-9. PubMed ID: 17059212 [TBL] [Abstract][Full Text] [Related]
16. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324 [TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406 [TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of LPS-binding protein/bactericidal permeability-increasing protein (LBP/BPI) from olive flounder, Paralichthys olivaceus. Nam BH; Ahn KJ; Kim YO; Kong HJ; Kim WJ; Kim HS; Lee SJ; Kim KK Vet Immunol Immunopathol; 2010 Feb; 133(2-4):256-63. PubMed ID: 19698997 [TBL] [Abstract][Full Text] [Related]
19. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]